Related Experiment Video
Updated: Aug 18, 2026

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach
Published on: February 21, 2019
Inhibition of protein kinase CK2 prevents the progression of glomerulonephritis
Masateru Yamada1, Susumu Katsuma, Tetsuya Adachi
1Pharmaceutical Research Laboratories, Toray Industries, Inc., 1111 Tebiro Kamakura, Kanagawa 248-8555, Japan.
Insights
Protein kinase CK2 drives glomerulonephritis (GN) progression, a leading cause of kidney failure. Inhibiting CK2 reduced inflammation and cell proliferation, offering a promising new therapeutic target for GN.
Area of Science:
- Nephrology
- Molecular Biology
- Immunology
Background:
- Glomerulonephritis (GN) is a major cause of chronic kidney disease and end-stage renal disease.
- Current immunosuppressive therapies for GN show limited efficacy.
- Protein kinase CK2 (CK2) has emerged as a potential factor in GN pathogenesis.
Purpose of the Study:
- To investigate the role of protein kinase CK2 in the progression of glomerulonephritis.
- To evaluate CK2alpha as a potential therapeutic target for GN.
Main Methods:
- cDNA microarray analysis to identify differentially expressed genes in GN.
- Analysis of CK2alpha expression in rat GN models and human renal biopsy samples.
- Administration of antisense oligodeoxynucleotide and CK2-specific inhibitors in rat GN models.
Main Results:
- CK2alpha, a subunit of CK2, was identified as a differentially expressed gene in GN.
- Overexpression of CK2alpha was observed in glomerular lesions of GN models and patients.
- CK2 inhibition ameliorated renal pathology by suppressing cell proliferation and inflammatory/fibrotic processes.
Conclusions:
- Protein kinase CK2 plays a critical role in the progression of immunogenic renal injury.
- CK2 inhibition effectively prevented GN progression in preclinical models.
- CK2 represents a potential therapeutic target for treating glomerulonephritis.
Abstract:
Glomerulonephritis (GN) is a progressive inflammation that may be caused by a variety of underlying disorders. It is the primary cause of chronic renal failure and end-stage renal disease, which require dialysis and transplantation worldwide. Immunosuppressive therapy has been used to treat GN clinically, but this treatment has had insufficient therapeutic effects. Here, we show that protein kinase CK2 is a key molecule in the progression of GN. cDNA microarray analysis identified CK2alpha, the catalytic subunit of CK2, as a GN-related, differentially expressed gene. Overexpression of CK2alpha was noted in the proliferative glomerular lesions in rat GN models and in renal biopsy specimens from lupus nephritis or IgA nephropathy patients. Administration of either antisense oligodeoxynucleotide against CK2alpha or low molecular weight CK2-specific inhibitors effectively prevented the progression of renal pathology in the rat GN models. The resolution of GN by CK2 inhibition may result from its suppression of extracellular signal-regulated kinase-mediated cell proliferation, and its suppression of inflammatory and fibrotic processes that are enhanced in GN. Our results show that CK2 plays a critical role in the progression of immunogenic renal injury, and therefore, CK2 is a potential target for GN therapy.
More Related Videos
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
07:38Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury II: Pathophysiology
Inhibition of Cdk Activity
Inhibition of CDK Activity
Nephrons
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...